Cresco Labs (CRLBF) Shares Outstanding (Weighted Average) (2019 - 2025)
Cresco Labs (CRLBF) has disclosed Shares Outstanding (Weighted Average) for 5 consecutive years, with $345.5 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Shares Outstanding (Weighted Average) rose 6.69% year-over-year to $345.5 million, compared with a TTM value of $345.5 million through Dec 2024, up 6.69%, and an annual FY2024 reading of $345.5 million, up 6.69% over the prior year.
- Shares Outstanding (Weighted Average) was $345.5 million for Q4 2024 at Cresco Labs, up from $323.8 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $345.5 million in Q4 2024 and bottomed at $210.5 million in Q4 2020.
- Average Shares Outstanding (Weighted Average) over 5 years is $288.0 million, with a median of $298.2 million recorded in 2022.
- The sharpest move saw Shares Outstanding (Weighted Average) rose 24.64% in 2021, then rose 6.69% in 2024.
- Year by year, Shares Outstanding (Weighted Average) stood at $210.5 million in 2020, then rose by 24.64% to $262.3 million in 2021, then increased by 13.66% to $298.2 million in 2022, then rose by 8.61% to $323.8 million in 2023, then increased by 6.69% to $345.5 million in 2024.
- Business Quant data shows Shares Outstanding (Weighted Average) for CRLBF at $345.5 million in Q4 2024, $323.8 million in Q4 2023, and $298.2 million in Q4 2022.